Welcome to our dedicated page for Healthcare Tr Amer SEC filings (Ticker: HR), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Healthcare Realty Trust Incorporated filings document its REIT business, medical outpatient building portfolio, operating partnership financing and public-company governance. Form 8-K reports cover material agreements and other events involving Healthcare Realty Holdings, L.P., senior unsecured indebtedness, exchangeable senior notes, commercial paper, Regulation FD presentations, auditor changes and executive appointments.
Proxy materials provide board, executive compensation, equity award, shareholder voting and governance disclosures. Other event and results filings address operating and financial performance, capital structure and corporate reporting matters related to the company’s U.S. outpatient medical real estate platform.
Healthcare Realty Trust Inc. reported an insider equity transaction involving its Executive Vice President and Chief Investment Officer, Andrew E. Loope. On 12/31/2025, 444 shares of common stock were withheld by the company at a price of $16.95 per share to cover required tax withholding related to the vesting of previously granted restricted shares.
After this tax-withholding transaction, Andrew E. Loope beneficially owned 166,382 shares of Healthcare Realty Trust Inc. common stock in direct ownership. The filing notes that the transaction may have been effected under a pre-arranged Rule 10b5-1 trading plan, as indicated by the available checkbox language.
Healthcare Realty Trust Incorporated established an at-the-market equity offering program for up to $1,000,000,000 of its Class A common stock, to be sold from time to time through multiple sales agents and via forward sale arrangements. Shares may be sold on the New York Stock Exchange or in privately negotiated transactions, and the company is not obligated to sell any shares and can suspend the program.
The company will issue shares under an existing shelf registration statement and has filed a prospectus supplement dated December 17, 2025. It plans to use net proceeds for general corporate purposes, including acquiring, developing, and redeveloping healthcare facilities and contributing capital to its operating partnership, and may also repay borrowings under its unsecured credit facility, in which affiliates of several sales agents are lenders and may receive a portion of those proceeds.
Healthcare Realty Trust Incorporated is establishing an at-the-market and forward equity program to offer and sell up to $1.0 billion of its Class A common stock from time to time through multiple sales agents and bank counterparties. Shares may be sold directly into the NYSE or via privately negotiated and block transactions, with sales agents and forward sellers earning up to 2.0% of gross proceeds.
The company plans to use net cash raised, including from physical settlement of forward sale agreements, for general corporate purposes such as acquiring, developing and redeveloping healthcare facilities, contributing capital to its operating partnership, and temporarily repaying borrowings under its Unsecured Credit Facility, which had $359 million outstanding as of December 15, 2025. Affiliates of several sales agents are lenders under that facility and will receive part of any repayment.
Healthcare Realty Trust is a healthcare-focused REIT with approximately $10.4 billion of gross investments in 519 consolidated properties totaling about 29.8 million square feet across 28 states as of September 30, 2025. The company highlights risks including tenant financial stress such as the Steward Health and Prospect Medical bankruptcies, potential dilution from this offering and forward sale agreements, interest rate and leverage exposure, and tax-law changes under the One Big Beautiful Bill Act affecting REIT rules and the qualified REIT dividend deduction.
Healthcare Realty Trust Inc. reported routine insider equity activity by an officer who serves as EVP and COO. On 12/11/2025, the issuer withheld 3,614 shares of common stock at $17.36 per share, and on 12/13/2025 it withheld an additional 5,682 shares at $17.18 per share.
According to the filing, these transactions reflect shares withheld by the company to meet required tax withholding obligations tied to the vesting of previously granted restricted shares, rather than open-market sales. After these transactions, the reporting person directly owned 279,891 shares of Healthcare Realty Trust common stock.
Healthcare Realty Trust Inc reported that an executive officer who serves as EVP and CIO had 908 common shares withheld on 12/13/2025 to satisfy required tax withholding obligations related to the vesting of previously granted restricted shares.
The transaction was reported at a price of $17.18 per share and left the officer with 166,826 common shares owned directly. The filing describes this as shares withheld by the issuer in connection with the restricted stock vesting rather than a typical discretionary share sale.
Healthcare Realty Trust Inc. disclosed an insider share disposition by its EVP and General Counsel, Andrew E. Loope. On 12/13/2025, 2,686 shares of common stock were surrendered at $17.18 per share to the company to satisfy required tax withholding tied to the vesting of previously granted restricted shares. After this tax-withholding transaction, he directly beneficially owned 160,747 common shares.
Healthcare Realty Trust Inc. disclosed an insider equity transaction involving its SVP & Chief Accounting Officer, Andrew E. Loope. On 12/13/2025, 2,481 shares of common stock were withheld by the company to cover required tax withholding related to the vesting of previously granted restricted shares, rather than being sold on the open market. The transaction was recorded at a price of $ 17.18 per share. Following this withholding event, Loope directly beneficially owned 107,546 shares of Healthcare Realty Trust common stock.
Healthcare Realty Trust Inc. reported a routine insider transaction by its SVP & Chief Accounting Officer. On 12/04/2025, the officer had 992 shares of common stock withheld by the company at a price of $17.46 per share to cover required tax withholding related to the vesting of previously granted restricted shares.
Following this tax-withholding transaction, the officer directly beneficially owns 110,027 shares of Healthcare Realty Trust Inc. common stock. The filing is administrative in nature and reflects no open-market purchase or sale.
Healthcare Realty Trust Inc.: Cohen & Steers filed Amendment No. 2 to Schedule 13G reporting beneficial ownership of 56,429,507 shares of common stock, representing 16.05% of the class as of 09/30/2025. Cohen & Steers, Inc. reports sole voting power over 42,824,616 shares and sole dispositive power over 56,429,507 shares.
Subsidiaries reported stakes include Cohen & Steers Capital Management, Inc. with 55,840,490 shares (15.88%), Cohen & Steers UK Limited with 544,974 shares (0.15%), and Cohen & Steers Ireland Limited with 44,043 shares (0.01%). The filing certifies the securities were acquired and are held in the ordinary course and not for the purpose of changing or influencing control.
Healthcare Realty Trust (HR) reported Q3 2025 results. Total revenues were $297.8 million, down from $315.4 million a year ago, as rental income eased to $287.4 million from $306.5 million. The company recorded a net loss attributable to common stockholders of $57.7 million versus a $93.0 million loss last year, as property impairments and interest expense continued to weigh on results.
Portfolio recycling accelerated. Year-to-date real estate dispositions reached $477.6 million in sale price, generating $447.3 million of net proceeds and $75.5 million of gains. Assets held for sale grew to 43 properties and two land parcels, with $604.7 million classified as held for sale, reflecting an ongoing pruning strategy.
Non-cash charges remained significant. The company recognized $104.4 million of real estate impairments in Q3 and $255.4 million year-to-date. Q3 interest expense was $52.6 million.
Balance sheet updates. HR repaid $250 million senior notes in May and entered a new $1.5 billion unsecured revolving credit facility on July 25, 2025, extended to 2029; $149 million was drawn at quarter-end. Operating cash flow for the nine months was $324.8 million. Shares outstanding were 351.6 million as of October 24, 2025.